ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study

Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors

(2013) Juliann Chmielecki et al.   NATURE GENETICS

Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

(2013) Dan R Robinson et al.   NATURE GENETICS

Solitary Fibrous Tumors and Hemangiopericytomas of the Meninges: Overlapping Pathological Features and Common Prognostic Factors Suggest the Same Spectrum of Tumors

(2011) Corinne Bouvier et al.   BRAIN PATHOLOGY

Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform

(2011) Paola Marcato et al.   CELL CYCLE

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype

(2011) S. Ricardo et al.   JOURNAL OF CLINICAL PATHOLOGY

Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity

(2010) Lin Wang et al.   INTERNATIONAL JOURNAL OF CANCER

IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting

(2010) Mihai Hajdu et al.   JOURNAL OF PATHOLOGY

Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma

(2009) Pooja Hingorani et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Molecular characterization of the response to chemotherapy in conventional osteosarcomas: Predictive value of HSD17B10 and IFITM2

(2009) Sébastien Salas et al.   INTERNATIONAL JOURNAL OF CANCER

Specific Genes Expressed in Association with Progesterone Receptors in Meningioma

(2008) E. B. Claus et al.   CANCER RESEARCH

Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

(2008) Satori A Marchitti et al.   Expert Opinion on Drug Metabolism & Toxicology